Capricor Therapeutics, Inc. · NASDAQ:CAPR
The Vanguard Group reported a 5.00% stake in Capricor Therapeutics, Inc. (Schedule 13G)
Event Dec 31, 2024 · Filed Jan 30, 2025
The Vanguard Group reported a 5.00% stake in Capricor Therapeutics, Inc., 2,276,784 shares, as a passive investor on Dec 31, 2024. Filed Jan 30, 2025 (Schedule 13G).
- Stake
- 5.00%
- Shares
- 2,276,784
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 5.00% | 2,276,784 |
Source
Related
- Capricor Therapeutics, Inc.
- The Vanguard Group
- Capricor Therapeutics, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Oct 30, 2025
- Schedule 13G · The Vanguard Group · Jul 29, 2025
- Schedule 13G/A · The Vanguard Group · Apr 30, 2025
- Schedule 13G/A · Millennium Management LLC · Oct 14, 2026
- Schedule 13G · Millennium Management LLC · Sep 14, 2026
- Schedule 13G · Millennium Management LLC · Aug 19, 2026
- Schedule 13G/A · Tang Capital Management LLC · Aug 14, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026